Today: 28 June 2026
Browse Category

NYSE:WST 23 October 2025 - 12 January 2026

AbbVie stock slips after $650 million RemeGen cancer-drug deal and Arizona plant buy

AbbVie stock slips after $650 million RemeGen cancer-drug deal and Arizona plant buy

AbbVie shares fell 0.6% to $218.81 after announcing a $650 million licensing deal with China’s RemeGen for the experimental cancer drug RC148. RemeGen could receive up to $4.95 billion in milestones and royalties. AbbVie also agreed to buy a device manufacturing plant in Tempe, Arizona, from West Pharmaceutical Services. The S&P health-care sector declined while the broader market rose.
12 January 2026
···
Wall Street Feels the Heat (and Thrill): Fed Cuts, Tariffs & Mega-Mergers Set NYSE Buzz

Stock Market Today 23.10.2025

West Pharmaceutical Services posted Q3 profit of $140 million, or $1.92 per share, beating estimates and raising FY25 guidance. Enphase Energy shares fell 11% in a month, with a 1-year total return of -54%, as valuation concerns persist. CBRE Group reported Q3 net income of $225 million and lifted full-year EPS guidance. Tractor Supply beat Q3 earnings estimates and raised its full-year EPS outlook to $2.06–$2.13.
23 October 2025
···

Stock Market Today

  • Top ETFs Holding SpaceX Stock After Its Historic IPO
    June 28, 2026, 11:05 AM EDT. SpaceX (NASDAQ: SPCX) debuted in the largest IPO on record but has dropped 23.4% in its first two weeks, highlighting the benefits of owning the stock via exchange-traded funds (ETFs) to reduce volatility. Nearly 110 ETFs hold SpaceX shares, with 27 featuring it among their top 15 holdings. Notable options include Fidelity Nasdaq Composite Index ETF (ONEQ), which tracks the broader Nasdaq Composite and holds SpaceX at 2.5% of its $10.9 billion portfolio with a low 0.21% expense ratio. Sector ETFs, particularly in communication services and aerospace, may increase exposure. ETFs offer diversified ways for investors to access SpaceX without direct stock volatility after its tumultuous IPO.

Latest articles

Intel (NASDAQ:INTC) edges lower, pulling back from $700 billion mark

Intel (NASDAQ:INTC) edges lower, pulling back from $700 billion mark

28 June 2026
Intel shares plunged 9.3% from Monday’s 52-week high, erasing $66 billion in market value and falling back below the $700 billion threshold as chip stocks tumbled on AI spending worries, with trading volume far outpacing short interest and sector profitability questions intensifying.
Ondas (NASDAQ:ONDS) drops 15% in volatile week after resale filing

Ondas (NASDAQ:ONDS) drops 15% in volatile week after resale filing

28 June 2026
Ondas Inc. (NASDAQ:ONDS) plunged 15.5% last week to $7.83 despite joining the Russell 3000 Index and announcing $40M+ in new defense orders; a June 26 filing registered 3.38M acquisition shares for resale, equal to 0.64% of shares, setting up a key test of real demand versus supply as index-driven volume fades ahead of the July 3 market holiday.
NVDA selloff drags $74 billion equity stake into spotlight

NVDA selloff drags $74 billion equity stake into spotlight

28 June 2026
Nvidia plunged 8.6% last week to $192.53, wiping out about $443 billion in equity value, as chip stocks suffered their worst week since April and Nvidia’s massive equity investment book added new risk to quarterly results; a further drop to $189.23 would mark a 20% slide from its May high.
Go toTop